Venous Market, Classification Tools, & Treatment Options

Question 1

Recurrent DVT, pulmonary embolism (PE), and post-thrombotic syndrome (PTS) are risk of thrombosis of ____ and ____.

Answer 1

femoral, iliac veins

Question 2

There are ___ main ways to classify VTE severity

Answer 2

4

Question 3

T or F: approximately 80% of patients with DVT in the iliofemoral veins are not being treated successfully with conventional therapy

Answer 3

True

Question 4

what stnads for clinical, etiological, anatomical, and pathophysiological

Answer 4

CEAP

Question 5

What was created to supplement CEAP and enable longitudinal patient surveillance

Answer 5

VCSS

Question 6

an assessment designed specifically for PTS

Answer 6

Villalta

Question 7

a patient reported quality of life (QoL) assessment

Answer 7

CIVIQ-20

Question 8

In which stages do patients become eligable for deep venous treatments according to CEAP?

Answer 8

stages C3-C6

Question 9

which venous classification tool asks physical and psychological questions?

Answer 9

CIVIQ-20

Question 10

The (‘16-‘26) CAGR for venous stenting is

Answer 10

7.9%

Question 11

Stages of _____/ _____ include: anitcoagulation, mechanical prophylaxis, and IVC filter

Answer 11

prevention/ management

Question 12

stages of ______ include: Throbosis, thrombectomy, and venous stent

Answer 12

intervention

Question 13

oldest and most common anticoagulation method, oral therapy

Answer 13

warfarin/ coumadin

Question 14

immediate effect and decreases fatal PE by 75% through injection

Answer 14

Heparin

Question 15

novel oral anticoagulaion, intented to eventually replace warfarin

Answer 15

NOAC: Rivaroxaban & Apixaban, Dabigatran